课题基金 / 基金详情

MECHANISMS OF ARTERIAL GRAFT HEALING

MECHANISMS OF ARTERIAL GRAFT HEALING
动脉移植物愈合机制
批准号:
6219707
负责人:
ALEXANDER W CLOWES
金额:
$7.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-05-01 至 2000-04-30

项目摘要

项目成果

ALEXANDER W CLOWES的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this project we are studying how intimal thickening develops in polytetrafluoroethelyne arterial grafts (PTFE) and in injured arteries in baboons. In the last year we pursued the hypothesis that nitric oxide (NO) is a major negative regulator of smooth muscle cell (SMC) growth in blood vessels, because high blood flow suppresses intimal thickening and induces the endothelial nitric oxide synthase gene (ecNOS). Our experiments with agents to block ecNOS cause vasoconstriction but do not induce SMC proliferation unless there is some degree of injury. In addition, we have performed experiments with antibodies to platelet derived growth factor receptor-( and ( (PDGF-R-( and () to define a role for PDGF in intimal thickening. PDGFR-( blockade inhibits intimal thickening induced by injury or a switch in blood flow. PDGFR-( blockade does not inhibit intimal hyperplasia but may cause cell death. We are currently working on the problem of how high blood flow causes regres sion of intimal thickening and are testing the hypothesis that NO may be causing smooth muscle cell apoptosis. We have also tried to extend our work to clinical application. We have developed an explant system and have shown that SMC growth in explants resembles very closely SMC growth in injured artery. We now hope to use the explant system to define the properties of human SMCs in saphenous vein explants. The ultimate goal is to provide a link between animal studies and outcome in humans. FUNDING NIH grants RR00166, HL30946, and HL18645. Hedin, U., Daum, G., and Clowes, A.W. Heparin inhibits thrombin-induced mitogen-activated protein kinase signaling in arterial smooth muscle cells. J. Vasc. Surg. 27:512-520, 1998. Daum, G., Kalmes, A., Levkau, B., Wang, Y., Davies, M.G., and Clowes, A.W. Pervanadate inhibits mitogen-activated protein kinase kinase-1 in a p38MAPK-dependent manner. FEBS Lett. 427:271-274, 1998. Daum, G., Levkau, B., Chamberlain, N.L., Wang, Y., and Clowes, A.W. The mitogen-activated kinase pathway contributes to vanadate toxicity in vascular smooth muscle cells. Molec. Cell. Biochem. 183:97-103, 1998. Clowes, A.W. Vascular surgery and vascular gene therapy. J. Cardiovasc. Surg. 39(Suppl 1) 185-188, 1998. Koyama, N., Kinsella, M.G., Wight, T.N., Hedin, U., and Clowes, A.W. Heparan sulfate proteoglycans mediate a potent inhibitory signal for migration of vascular smooth muscle cells. Circ. Res. 83:305-313, 1998. Mattsson, E.J.R., Geary, R.L., Kraiss, L.W., Vergel, S., Liao, J.K., Corson, M.A., Au, Y.P.T., Hanson, S.R., and Clowes, A.W. Is smooth muscle growth in primate arteries regulated by endothelial nitric oxide synthase? J. Vasc. Surg. 28:514-521, 1998. Fischer, J.W., Davies, M.G., Wight, T.N., and Clowes, A.W. Versican is the predominant proteoglycan in flow accelerated neointimal hyperplasia of endothelialized baboon vascular grafts. Circulation 98 (17 suppl. I) 228, 1998 (abstract). [This project was also reported in the Other Research Affil section.]
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Syndecan-1 and the Arterial Response to Injury
  • 批准号:
    8286917
  • 项目类别:
  • 资助金额:
    $41.29万
  • 财政年份:
    2010
  • 负责人:
    ALEXANDER W CLOWES
  • 依托单位:
Syndecan-1 and the Arterial Response to Injury
  • 批准号:
    8489325
  • 项目类别:
  • 资助金额:
    $39.34万
  • 财政年份:
    2010
  • 负责人:
    ALEXANDER W CLOWES
  • 依托单位:
Syndecan-1 and the Arterial Response to Injury
  • 批准号:
    7982926
  • 项目类别:
  • 资助金额:
    $43.1万
  • 财政年份:
    2010
  • 负责人:
    ALEXANDER W CLOWES
  • 依托单位:
Syndecan-1 and the Arterial Response to Injury
  • 批准号:
    8118086
  • 项目类别:
  • 资助金额:
    $41.95万
  • 财政年份:
    2010
  • 负责人:
    ALEXANDER W CLOWES
  • 依托单位:
海外基金